Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: A study of complexin mRNAs

Molecular Psychiatry

Volumn 5, Issue 4, 2000, Pages 425-432

  Eastwood, S L ^b   Harrison, P J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Affective disorder; Depressive disorder; Gene expression; Hippocampus; Mood disorder; Neuropathology; Psychosis; Synaptic protein

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORPROMAZINE; COMPLEXIN; HALOPERIDOL; LITHIUM; MESSENGER RNA; NEUROLEPTIC AGENT; PROTEIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0008024807     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000741     Document Type: Article

References (29)

1. 1 Friston K, Frith C. Schizophrenia: a disconnection syndrome? Clin Neurosci 1995; 3: 89-97.
2. 2 Andreasen NC. A unitary model of schizophrenia. Bleuler's 'fragmented phrene' as schizencephaly. Arch Gen Psychiatry 1999; 56: 781-787.
3. 3 Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593-624.
4. 4 Eastwood SL, Burnet PWJ, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66: 309-319.
5. 5 Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69: 339-343.
6. 6 Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P, Honer WG. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cerebr Ctx 1998; 8: 261-268.
7. 7 Eastwood SL, Harrison PJ. Detection and quantification of hippocampal synaptophysin mRNA in schizophrenia using autoclaved formalin-fixed paraffin-embedded sections. Neuroscience 1999; 93: 99-106.
8. 8 Vawter MP, Howard AL, Hyde TM, Kleinman JE, Freed WJ. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry 1999; 4: 467-475.
9. 9 Harrison PJ, Eastwood SL. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 1998; 352: 1669-1673.
10. 10 Takahashi S, Yamamoto H, Matsuda Z, Ogawa M, Yagyu K, Taniguchi T et al. Identification of two highly homologous presynaptic proteins distinctly localised at the dendritic and somatic synapses. FEBS Lett 1995; 368: 455-460.
11. 11 Ishizuka T, Saisu H, Odani S, Kumanishi T, Abe T. Distinct regional distribution in the brain of messenger RNAs for the two isoforms of synaphin associated with the docking/fusion complex. Neuroscience 1999; 88: 295-306.
12. 12 Yamada M, Saisu H, Ishizuka T, Takahashi H, Abe T. Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types. Neuroscience 1999; 93: 7-18.
13. 13 Eastwood SL, Burnet PWJ, Harrison PJ. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse (in press).
14. 14 Johnston NL, Cerevnak J, Shore AD, Torrey EF, Yolken RH. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. J Neurosci Meth 1997; 77: 83-92.
15. 15 Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200: 151-154.
16. 16 Burnet PWJ, Harrison PJ. Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia. Biol Psychiatry 2000; 47: 80-83.
17. 17 Honer G, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999; 91: 1247-1255.
18. 18 Eastwood SL, Cairns NJ, Harrison PJ. Synaptophysin gene expression in schizophrenia. An investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry 2000; 176: 236-242.
19. 19 Harrison PJ, Burnet PWJ, Falkai P, Bogerts B, Eastwood SL. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex. Schizophr Res 1997; 26: 93-102.
20. 20 Esiri MM, Pearson RCA. Perspectives from other diseases and lesions. In: Harrison PJ, Roberts GW (eds). The Neuropathology of Schizophrenia and its Interpretation. Oxford University Press: Oxford (in press).
21. 21 Ono S, Baux G, Sekiguchi M, Fossier P, Morel NF, Nihonmatsu I et al. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals. Eur J Neurosci 1998; 10: 2143-2152.
22. 22 Takahashi S, Ujihara H, Huang GZ, Yagyu K, Sanbo M, Kaba H et al. Reduced hippocampal LTP in mice lacking a presynaptic protein, complexin II. Eur J Neurosci 1999; 11: 2359-2366.
23. 23 Öngür D, Drevets DC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
24. 24 Rajkowska G, Miguel-Hidalgo JJ, Wei JR, Dilley G, Pittman SD, Meltzer HY et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-1098.
25. 25 Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. Reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998; 44: 98-97.
26. 26 Baumann B, Bogerts B. The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr Res 1999; 39: 141-148.
27. 27 Harrison PJ. The neuropathological effects of antipsychotic drugs. Schizophr Res 1999; 40: 87-99.
28. 28 Benes FM. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol Psychiatry 1999; 46: 589-599.
29. 29 Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45: 395-402.